Angiographic and clinical outcome of SARS-CoV-2 positive patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: A collaborative, individual patient data meta-analysis of six registry-based studies European Journal of Internal Medicine
暂无分享,去创建一个
Z. Siudak | A. Gershlick | A. Silverio | M. Verdoia | D. Jones | B. Cid-Álvarez | T. Tokarek | T. Kite | Daniel A. Jones
[1] M. Brandi. Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic? , 2021, Reviews in Endocrine and Metabolic Disorders.
[2] A. Bollmann,et al. Sex Differences in Clinical Course and Intensive Care Unit Admission in a National Cohort of Hospitalized Patients with COVID-19 , 2021, Journal of clinical medicine.
[3] H. Suryapranata,et al. COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction , 2021, Heart.
[4] M. Morello,et al. Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19. , 2021, European review for medical and pharmacological sciences.
[5] D. Tousoulis,et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA) , 2021, Cardiovascular research.
[6] G. De Luca,et al. COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives , 2021, Oxidative medicine and cellular longevity.
[7] Z. Siudak,et al. Treatment Delay and Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction during the COVID-19 Pandemic , 2021, Journal of clinical medicine.
[8] J. C. Rama-Merchán,et al. Angiographic and Clinical Profile of Patients With COVID-19 Referred for Coronary Angiography During SARS-CoV-2 Outbreak: Results From a Collaborative, European, Multicenter Registry , 2021, Angiology.
[9] Massimo Siviglia,et al. Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry , 2021, Atherosclerosis.
[10] M. Karabacak,et al. Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry) , 2021, Journal of Thrombosis and Thrombolysis.
[11] B. Gersh,et al. International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19 , 2021, Journal of the American College of Cardiology.
[12] Brian C. Case,et al. Initial Findings From the North American COVID-19 Myocardial Infarction Registry , 2021, Journal of the American College of Cardiology.
[13] G. De Luca,et al. Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients , 2021, BMC Cardiovascular Disorders.
[14] Massimo Siviglia,et al. Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI , 2020, Journal of the American College of Cardiology.
[15] M. Ciccarelli,et al. Timing of national lockdown and mortality in COVID-19: The Italian experience , 2020, International Journal of Infectious Diseases.
[16] D. Xiang,et al. Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China , 2020, Journal of the American College of Cardiology.
[17] A. Baumbach,et al. High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction , 2020, Journal of the American College of Cardiology.
[18] C. Siu,et al. Impact of coronavirus disease 2019 (COVID‐19) outbreak on outcome of myocardial infarction in Hong Kong, China , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[19] C. Schmidt,et al. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic , 2020, Journal of the American College of Cardiology.
[20] Mohammad Madjid,et al. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. , 2020, JAMA cardiology.
[21] H. Suryapranata,et al. Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease. , 2015, Diabetes & metabolism.
[22] Richard D Riley,et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data: The PRISMA-IPD Statement , 2015 .
[23] H. Suryapranata,et al. Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI. , 2013, International journal of cardiology.
[24] G. Stone,et al. Impact of Diabetes on Long-Term Outcome After Primary Angioplasty , 2013, Diabetes Care.
[25] D. Dudek,et al. Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb–IIIa inhibitors: insights from the EGYPT cooperation , 2010, Journal of Thrombosis and Thrombolysis.
[26] G. De Luca,et al. Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials , 2009, European heart journal.
[27] A. Kastrati,et al. Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes. , 2008, Journal of the American College of Cardiology.
[28] J. Ottervanger,et al. Impact of statin therapy at discharge on 1-year mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty. , 2006, Atherosclerosis.
[29] J. Ottervanger,et al. Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. , 2005, European heart journal.
[30] Felix Zijlstra,et al. Prognostic Assessment of Patients With Acute Myocardial Infarction Treated With Primary Angioplasty: Implications for Early Discharge , 2004, Circulation.
[31] J. Ottervanger,et al. Impaired Myocardial Perfusion Is a Major Explanation of the Poor Outcome Observed in Patients Undergoing Primary Angioplasty for ST-Segment–Elevation Myocardial Infarction and Signs of Heart Failure , 2004, Circulation.
[32] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[33] Donald Rubin,et al. Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.
[34] D B Rubin,et al. Multiple imputation in health-care databases: an overview and some applications. , 1991, Statistics in medicine.
[35] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[36] B. Ibáñez,et al. In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients , 2021, EuroIntervention.
[37] J. Rumsfeld,et al. Clinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention. , 2009, JACC. Cardiovascular interventions.